Currently prescribed drugs in the UK that could up or downregulate ACE2 in COVID-19 disease: A systematic review (2020)
Attributed to:
Prevention of Diabetes and Related Metabolic Disorders in High Risk Groups
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.05.19.20106856
Publication URI: http://dx.doi.org/10.1101/2020.05.19.20106856
Type: Preprint